Cheng Jonathan C, Schultheiss Timothy E, Nguyen Khanh H, Wong Jeffrey Y C
Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA 91010-3000, USA.
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):351-7. doi: 10.1016/j.ijrobp.2007.09.043. Epub 2007 Dec 31.
To assess the incidence of acute gastrointestinal (GI) and genitourinary (GU) injury and the dose-volume response in patients with clinically localized prostate cancer treated with image-guided radiotherapy using helical tomotherapy.
Between November 2004 and March 2007, 146 consecutive patients with localized prostate cancer were treated with helical tomotherapy at the City of Hope Medical Center. Of the 146 patients, 70 had undergone prostatectomy. Acute GI and GU toxicities were evaluated using the Radiation Therapy Oncology Group/European Organization for Research and Cancer of Medical scoring system. Events were scored for patients developing Grade 2 or greater morbidity within 90 days after the end of radiotherapy (RT). The dosimetric parameters included the minimal dose received by the highest 10%, 20%, 50%, 80%, and 90% of the target volume, the mean rectal dose, minimal rectal dose, maximal rectal dose, and the volume receiving > or =45, > or =65, and > or =70 Gy. These variables, plus the status of radical prostatectomy, hormonal therapy, RT techniques, and medical conditions, were included in a multivariate logistic regression analysis. A goodness-of-fit evaluation was done using the Hosmer-Lemeshow statistic.
A dose-response function for acute GI toxicity was elicited. The acute GI Grade 2 or greater toxicity was lower in the definitive RT group than in the postoperative RT group (25% vs. 41%, p <0.05). Acute GU Grade 2 or greater toxicity was comparable between the two groups. No grade 3 or greater complications were observed. No dosimetric variable was significant for GU toxicity. For acute GI toxicity, the significant dosimetric parameters were the minimal dose received by 10%, 20%, and 50% of the target volume and the mean rectal dose; the most predictive parameter was the minimal dose received by 10% of the target volume. The dose-modifying factor was 1.2 for radical prostatectomy.
The results of our study have shown that acute rectal symptoms are dose-volume related. Postprostatectomy RT resulted in a greater incidence of acute GI toxicity than did definitive RT. For postoperative RT, it would be prudent to use different dose-volume limits.
评估采用螺旋断层放射治疗的临床局限性前列腺癌患者急性胃肠道(GI)和泌尿生殖系统(GU)损伤的发生率及剂量-体积反应。
2004年11月至2007年3月期间,希望之城医疗中心对146例连续性局限性前列腺癌患者采用螺旋断层放射治疗。在这146例患者中,70例曾接受前列腺切除术。采用放射治疗肿瘤学组/欧洲癌症研究与治疗组织的医学评分系统评估急性GI和GU毒性。对放疗(RT)结束后90天内发生2级或更高级别发病率的患者进行事件评分。剂量学参数包括靶体积最高10%、20%、50%、80%和90%所接受的最小剂量、直肠平均剂量、直肠最小剂量、直肠最大剂量以及接受≥45 Gy、≥65 Gy和≥70 Gy的体积。这些变量,加上根治性前列腺切除术的状态、激素治疗、RT技术和医疗状况,纳入多因素逻辑回归分析。使用Hosmer-Lemeshow统计量进行拟合优度评估。
得出急性GI毒性的剂量-反应函数。根治性RT组急性GI 2级或更高级别毒性低于术后RT组(25%对41%,p<0.05)。两组急性GU 2级或更高级别毒性相当。未观察到3级或更高级别的并发症。没有剂量学变量对GU毒性有显著意义。对于急性GI毒性,显著的剂量学参数是靶体积10%、20%和50%所接受的最小剂量以及直肠平均剂量;最具预测性的参数是靶体积10%所接受的最小剂量。根治性前列腺切除术的剂量修正因子为1.2。
我们的研究结果表明,急性直肠症状与剂量-体积相关。前列腺切除术后RT导致急性GI毒性的发生率高于根治性RT。对于术后RT,谨慎使用不同的剂量-体积限制是明智的。